Last updated on August 2017

A Phase 3, Multicenter, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension in the Treatment of Adenoviral Conjunctivitis.


Brief description of study

A Phase 3, Multicenter, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension in the Treatment of Adenoviral Conjunctivitis.

Detailed Study Description

The Primary Objective if this study is to evaluate the efficacy of SHP640 based on clinical resolution (Defined as absence of bulbar conjunctival injection and ocular conjunctival discharge) compared with placebo in the treatment of subject with Adenoviral Conjunctivitis in the study at Visit 3(Day5).

Clinical Study Identifier: TX152342

Find a site near you

Start Over

The Eye Care Institute

1536 Story Ave Louisville, KY USA
  Connect »